IG
GMED icon

ING Group’s Globus Medical GMED Stock Holding History

ING Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11,734
Closed -$496K – 591
2019
Q2 		$496K Buy
11,734
+66
+0.6% +$2.87K 0.01% 518
2019
Q1 		$577K Buy
11,668
+15
+0.1% +$679 0.01% 415
2018
Q4 		$504K Buy
+11,653
New +$581K 0.01% 460
2018
Q3 		– Sell
-7,837
Closed -$395K – 804
2018
Q2 		$395K Buy
+7,837
New +$409K 0.01% 533
2018
Q1 		– Sell
-10,938
Closed -$450K – 774
2017
Q4 		$450K Buy
10,938
+2,095
+24% +$73.3K 0.01% 523
2017
Q3 		$263K Buy
8,843
+59
+0.7% +$1.8K 0.01% 737
2017
Q2 		$291K Buy
+8,784
New +$276K 0.01% 697

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

ING Group's GMED Position: Q3 2019 in Review

ING Group sold out of Globus Medical (GMED) in Q3 2019, closing a stake of 11,734 shares — an estimated $496K sold.

ING Group first reported a position in GMED in Q2 2017 and held it in 7 quarters. The position peaked at $577K in Q1 2019. 268 funds tracked by Wall St. Rank hold GMED as of Q3 2019.

  • ING Group reported no remaining Globus Medical position as of Q3 2019 after selling out during the quarter.
  • ING Group sold 11,734 Globus Medical shares in Q3 2019, an estimated $496K.
  • ING Group first reported a position in Globus Medical in Q2 2017 and held it in 7 quarters.
  • ING Group's Globus Medical position peaked at $577K in Q1 2019.
  • 268 funds tracked by Wall St. Rank held Globus Medical as of Q3 2019.

Based on ING Group's 13F filing for Q3 2019, filed 8 Nov 2019.